Yahoo Finance

Theratechnologies Provides Update on EGRIFTA SV® Supply

MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and ...
Nasdaq

Theratechnologies resumes production of Egrifta SV

Theratechnologies (THTX) announced that the production of Egrifta SV has resumed following a voluntary shutdown of the company’s contract manufacturer’s facility to address observations from an ...
Nasdaq

Theratechnologies Gets FDA Approval Of Prior Approval Supplement For EGRIFTA SV SBLA

(RTTNews) - Theratechnologies (TH.TO, THTX) announced the FDA has approved the company's Prior Approval Supplement to the supplemental biologics license application for EGRIFTA SV, or tesamorelin for ...
Monthly Prescribing Reference

Egrifta Sv

Tesamorelin 2mg; per vial; lyophilized pwd for SC inj after reconstitution; preservative-free; contains mannitol. Store at room temperature at 20°C to 25°C (68°F to 77°F) in the original box to ...
manilatimes

Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment

MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies” or the "Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and ...
Yahoo Finance

Theratechnologies Resumes Distribution of EGRIFTA SV®

MONTREAL, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company focused on the ...
Mena FN

Theratechnologies Provides Update On EGRIFTA SV® Supply

(MENAFN- GlobeNewsWire - Nasdaq) MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the“Company”) (TSX: TH) (NASDAQ ...
The Globe and Mail

Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA

MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that ...